New web tool aims to lighten load for dementia caregivers
NCT ID NCT03536975
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a web platform designed for people with mild cognitive impairment or mild to moderate dementia and their primary caregivers. The platform offers social networks, activities, and games to improve quality of life and help them stay in the community longer. Researchers compared 48 participants who used the platform with those who did not, measuring caregiver burden and other health and social outcomes over 18 months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- CAREGIVERSPRO-MMD web platform
- What this could lead to
- If it works, this could provide a practical tool to ease caregiver burden and help people with dementia live at home longer.
- What could go wrong
- This is a small pilot study with only 48 participants, so results may not apply widely. The platform may not show clear benefits or be difficult for some users.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
48 people
The number who actually took part.
- Started
-
Dec 2017
- Finished
-
Apr 2019
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * For patients People, aged 50 and over, living in the community, who are able to give informed consent. Diagnosed with mild cognitive impairment (MCI) according to Petersen criteria or mild to moderate dementia diagnosed according on DSM-IV criteria. Having a Clinical Dementia Rating (CDR) of 0.5 for MCI, 1-2 for mild to moderate dementia Having a Mini-Mental Exam score (MMSE) between 30 and 25 (inclusive) for MCI, and between 24 and 10 (inclusive) for dementia. Having a primary caregiver, familiar (or not), informal (or not) identified and also included in the study. Be willing to use Information Technology and Communications (ICT) according to the investigator criteria. Affiliated to the social security system. * For caregivers People, aged 18 years and over, with no diagnosis or no evidence of mild cognitive impairment or mild to moderate dementia (according DSM-IV criteria), who are able to give informed consent and with an intention to complete the study. Primary caregivers, informal (or not), familiar (or not), of person with mild cognitive impairment or mild to moderate dementia People with Internet access and basic knowledge and skills in managing internet and social networks, or keen to learn, according to the investigator criteria Having a Geriatric Depression Scale (GDS-Yesavage - 15 items) score less than 11 at the time of entry into the trial indicating no severe depressive symptoms or for people \< 50 years a MADRS \< 15 Having no specific conditions (evaluated by the investigator) reducing their physical abilities below the norm for their age that would limit or impair CAREGIVERSPRO-MMD platform use. Be willing to use Information Technology and Communications (ICT) according to the investigator criteria Affiliated to the social security system Exclusion Criteria: * Terminal or severe illness with survival prognosis less than 18 months * Not speaking nor reading French * Enrolled in another clinical trial * For the patients : Having delusions, hallucinations, behavioural disturbances, that may interfere with the use of Information and Communications Technology (ICT) tools ; Under guardianship and/or under curatorship
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cognitive impairment, mild are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Intercommunal Elbeuf Louviers
Elbeuf, France
-
Rouen University Hospital
Rouen, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a quick sweat and pupil test spot early signs of dementia?
- A new web tool aims to ease tough tech decisions for dementia families
- Can a simple exercise program boost brain and balance in aging minds?
- Could an Immune-Modulating drug slow early Alzheimer's?
- Can math training rewire Kids' brains? stanford launches new study
- Heart disease and brain health: new study seeks clues in 2,352 patients